These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions. Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449 [TBL] [Abstract][Full Text] [Related]
5. Possible serotonin syndrome associated with buspirone added to fluoxetine. Manos GH Ann Pharmacother; 2000; 34(7-8):871-4. PubMed ID: 10928399 [TBL] [Abstract][Full Text] [Related]
6. Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex. Yoshino T; Nisijima K; Katoh S; Yui K; Nakamura M Neurochem Int; 2002 Apr; 40(4):355-60. PubMed ID: 11792466 [TBL] [Abstract][Full Text] [Related]
7. Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray. de Bortoli VC; Nogueira RL; Zangrossi H Psychopharmacology (Berl); 2006 Jan; 183(4):422-8. PubMed ID: 16258751 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors. Barton CL; Hutson PH Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679 [TBL] [Abstract][Full Text] [Related]
10. The clinical utility of pharmacological agents that act at serotonin receptors. Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. He M; Sibille E; Benjamin D; Toth M; Shippenberg T Brain Res; 2001 May; 902(1):11-7. PubMed ID: 11376590 [TBL] [Abstract][Full Text] [Related]
12. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response. Blier P; Bergeron R; de Montigny C Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104 [TBL] [Abstract][Full Text] [Related]
13. [Anxiolytic effects of serotonin reuptake inhibitors and their mechanism of action]. Hashimoto S Hokkaido Igaku Zasshi; 2000 Nov; 75(6):421-36. PubMed ID: 11193934 [TBL] [Abstract][Full Text] [Related]
15. [Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine]. Le Poul E; Lima L; Laporte AM; Even C; Doucet E; Fattaccini CM; Laaris N; Hamon M; Lanfumey L Encephale; 1995; 21(2):123-32. PubMed ID: 7781583 [TBL] [Abstract][Full Text] [Related]
16. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist. Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683 [TBL] [Abstract][Full Text] [Related]
17. Fluoxetine selectively alters 5-hydroxytryptamine1A and gamma-aminobutyric acidB receptor-mediated hyperpolarization in area CA1, but not area CA3, hippocampal pyramidal cells. Beck SG; Birnstiel S; Choi KC; Pouliot WA J Pharmacol Exp Ther; 1997 Apr; 281(1):115-22. PubMed ID: 9103487 [TBL] [Abstract][Full Text] [Related]
18. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine. Li XM; Perry KW; Wong DT Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599 [TBL] [Abstract][Full Text] [Related]
19. Serotonergic mechanisms and current and future psychiatric practice. Dubovsky SL; Thomas M J Clin Psychiatry; 1995; 56 Suppl 2():38-48. PubMed ID: 7844106 [TBL] [Abstract][Full Text] [Related]
20. Buspirone as an antidote to SSRI-induced bruxism in 4 cases. Bostwick JM; Jaffee MS J Clin Psychiatry; 1999 Dec; 60(12):857-60. PubMed ID: 10665633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]